###begin article-title 0
Phosphofructo-1-Kinase Deficiency Leads to a Severe Cardiac and Hematological Disorder in Addition to Skeletal Muscle Glycogenosis
###end article-title 0
###begin p 1
Conceived and designed the experiments: MG AP ER JR JEF FB. Performed the experiments: MG AP AR ER JR AA AS BA JEF FB. Analyzed the data: MG AP ER JR JEF FB. Wrote the paper: MG FB.
###end p 1
###begin p 2
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PFKM</italic>
###xml 610 613 610 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 606 613 606 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 639 642 639 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 635 642 635 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 933 936 933 936 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 929 936 929 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 1231 1234 1231 1234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1227 1234 1227 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 1662 1665 1662 1665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1658 1665 1658 1665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 643 647 <span type="species:ncbi:10090">mice</span>
###xml 937 941 <span type="species:ncbi:10090">mice</span>
###xml 1235 1239 <span type="species:ncbi:10090">mice</span>
###xml 1666 1670 <span type="species:ncbi:10090">mice</span>
Mutations in the gene for muscle phosphofructo-1-kinase (PFKM), a key regulatory enzyme of glycolysis, cause Type VII glycogen storage disease (GSDVII). Clinical manifestations of the disease span from the severe infantile form, leading to death during childhood, to the classical form, which presents mainly with exercise intolerance. PFKM deficiency is considered as a skeletal muscle glycogenosis, but the relative contribution of altered glucose metabolism in other tissues to the pathogenesis of the disease is not fully understood. To elucidate this issue, we have generated mice deficient for PFKM (Pfkm-/-). Here, we show that Pfkm-/- mice had high lethality around weaning and reduced lifespan, because of the metabolic alterations. In skeletal muscle, including respiratory muscles, the lack of PFK activity blocked glycolysis and resulted in considerable glycogen storage and low ATP content. Although erythrocytes of Pfkm-/- mice preserved 50% of PFK activity, they showed strong reduction of 2,3-biphosphoglycerate concentrations and hemolysis, which was associated with compensatory reticulocytosis and splenomegaly. As a consequence of these haematological alterations, and of reduced PFK activity in the heart, Pfkm-/- mice developed cardiac hypertrophy with age. Taken together, these alterations resulted in muscle hypoxia and hypervascularization, impaired oxidative metabolism, fiber necrosis, and exercise intolerance. These results indicate that, in GSDVII, marked alterations in muscle bioenergetics and erythrocyte metabolism interact to produce a complex systemic disorder. Therefore, GSDVII is not simply a muscle glycogenosis, and Pfkm-/- mice constitute a unique model of GSDVII which may be useful for the design and assessment of new therapies.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 600 605 <span type="species:ncbi:9606">human</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 661 666 <span type="species:ncbi:9606">human</span>
###xml 667 675 <span type="species:ncbi:9606">patients</span>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
Type VII glycogen storage disease (GSDVII), or Tarui disease, is a rare genetic disorder characterized by glycogen accumulation in skeletal muscle. The molecular cause is loss of activity of the muscle isoform of phosphofructokinase (PFK), which phosphorylates fructose-6-phosphate to fructose-1,6-bisphosphate, commiting glucose to glycolysis. Entry of fructose-6-phosphate into glycolysis is thus blocked, increasing glycogen synthesis and accumulation. Clinical manifestations of the disease are heterogeneous, ranging from exercise intolerance to early childhood death. To further understand the human pathology, we generated mice lacking muscle PFK. As in human patients, these mice showed severe exercise intolerance, hemolysis, and most died young. Lack of glycolysis in skeletal muscle also causes alterations in bioenergetics and compensatory changes in key metabolic genes. Additionally, although erythrocytes retained 50% of normal PFK activity, their overall functionality was impaired, aggravating the muscle dysfunction. Moreover, marked metabolic alterations in the heart lead to chronic hypertrophy, suggesting that cardiac pathology in GSDVII may be underestimated or misdiagnosed. This study indicates that this disease is more complex than a muscle glycogenosis and that symptoms other than those classically described should be taken into consideration. Finally, this animal model will enable us to develop new therapeutic approaches and better diagnostic tools.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PFKM</italic>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PFKL</italic>
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PFKP</italic>
###xml 359 362 359 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Vora1">[1]</xref>
###xml 564 567 564 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Vora2">[2]</xref>
###xml 568 571 568 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Dunaway1">[3]</xref>
###xml 594 598 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PFKM</italic>
###xml 710 713 710 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Tarui1">[4]</xref>
###xml 1134 1137 1134 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Raben1">[5]</xref>
###xml 1313 1316 1313 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Servidei1">[6]</xref>
###xml 1317 1320 1317 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Amit1">[7]</xref>
###xml 771 779 <span type="species:ncbi:9606">patients</span>
###xml 1405 1413 <span type="species:ncbi:9606">patients</span>
Phosphofructo-1-kinase (PFK) is a tetrameric enzyme that phosphorylates fructose-6-phosphate to fructose-1,6-bisphosphate, committing glucose to glycolysis. Three PFK isoenzymes, encoded by separate genes, have been identified in mammals: muscle-type (PFKM), liver-type (PFKL), and platelet-type (PFKP), all of which are expressed in a tissue specific manner [1]. Thus, skeletal muscle expresses only PFKM homotetramers, liver mainly PFKL homotetramers, although it can also express M- and P-type subunits, while erythrocytes contain PFKM and PFKL heterotetramers [2],[3]. Several mutations in PFKM cause type VII glycogen storage disease (GSDVII), which is a rare disease described by Tarui (Tarui's disease) [4]. GSDVII is inherited as an autosomal recessive trait and patients show loss of PFK activity in skeletal muscle and also partial deficiency in erythrocytes. Although GSDVII is characterized by accumulation of glycogen in skeletal muscle and hemolysis, there are several subtypes with different clinical features. No genotype-phenotype correlation explaining the phenotypic heterogeneity of the disease has been described [5]. It can be detected as a severe form with onset in infancy with hypotonia, limb weakness, progressive myopathy and respiratory failure leading to death early in the childhood [6],[7]. Neonatal mortality may be responsible for the low number of cases diagnosed. Adult patients with the classical form of the disease develop myopathy with muscle cramps and myoglobinuria when exercised as well as compensated haemolytic anemia.
###end p 6
###begin p 7
###xml 410 413 410 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Stollberger1">[8]</xref>
###xml 708 711 708 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Giger1">[9]</xref>
###xml 712 716 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Giger2">[10]</xref>
###xml 826 830 826 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Vora3">[11]</xref>
###xml 1181 1185 1181 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 1185 1188 1185 1188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 158 163 <span type="species:ncbi:9606">human</span>
###xml 164 172 <span type="species:ncbi:9606">patients</span>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
###xml 703 707 <span type="species:ncbi:9615">dogs</span>
###xml 742 746 <span type="species:ncbi:9615">dogs</span>
###xml 803 808 <span type="species:ncbi:9606">human</span>
###xml 935 939 <span type="species:ncbi:10090">mice</span>
###xml 1189 1194 <span type="species:ncbi:10090">mouse</span>
GSDVII is considered as a muscle glycogenosis. Although, alterations in oxidative metabolism and bioenergetics in skeletal muscle have also been described in human patients, few data on metabolic and fiber structural changes are available. In addition, the contribution of altered glucose metabolism in other tissues to the pathogenesis of the disease is not fully understood and may also lead to misdiagnosis [8]. No therapies are available for GSDVII patients and development of effective treatments requires both understanding the molecular mechanisms that lead to the disease and the development of animal models in which to test new treatments. Inherited PFKM deficiency has only been described in dogs [9],[10]. However, PFKM deficient dogs exhibit mild muscle disease not closely reproducing the human muscle pathology [11]. In the present study, to determine the molecular mechanisms underlying this disease, we have generated mice lacking the muscle isoform of PFK. We found that PFKM deficiency leads to marked alterations in muscle bioenergetics and erythrocyte metabolism that interact to produce the complex pathology characteristic of GSDVII. The availability of the Pfkm-/- mouse model allows the study of GSDVII as a systemic disorder, not simply as muscle glycogenosis.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
Pfkm-/- mice exhibit high lethality and skeletal muscle glycogenosis
###end title 9
###begin p 10
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 265 274 265 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g001">Figure 1A</xref>
###xml 326 329 326 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 322 329 322 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>+/&#8722;</sup></italic>
###xml 338 341 338 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 334 341 334 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 408 417 408 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g001">Figure 1B</xref>
###xml 424 427 424 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 420 427 420 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>+/&#8722;</sup></italic>
###xml 463 467 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 473 477 <span type="species:ncbi:10090">mice</span>
To generate Pfkm deficient mice, standard gene-targeting methods in mouse embryonic stem cells were used. Homologous recombination of the targeting construct resulted in the deletion of the 5' promoter region and exon 3, which contains the translation start codon (Figure 1A). The presence of heterozygous and homozygous (Pfkm+/- and Pfkm-/-) mice was confirmed by Southern blot (data not shown) and by PCR (Figure 1B). Pfkm+/- mice were viable and fertile while Pfkm-null mice presented high lethality around weaning (about 60%) and those surviving died early during adulthood, at around 3 to 6 month of age, although few animals survived for more than one year.
###end p 10
###begin title 11
###xml 18 21 18 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Generation of Pfkm-/- mice and the effect of Pfkm ablation on skeletal muscle glucose metabolism.
###end title 11
###begin p 12
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hind</italic>
###xml 153 156 153 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 182 185 182 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</sup>
###xml 236 242 236 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSV-tk</italic>
###xml 419 422 419 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</italic>
###xml 429 432 429 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 425 432 425 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>+/&#8722;</sup></italic>
###xml 434 437 434 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</italic>
###xml 447 450 447 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 443 450 443 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 606 610 606 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 760 764 760 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 848 869 848 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 1113 1116 1111 1114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1109 1116 1107 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 1181 1202 1179 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 1256 1259 1254 1257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1252 1259 1250 1257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 1372 1373 1368 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1382 1383 1378 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1389 1392 1385 1388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
###xml 903 907 <span type="species:ncbi:10090">mice</span>
###xml 1123 1127 <span type="species:ncbi:10090">mice</span>
###xml 1266 1270 <span type="species:ncbi:10090">mice</span>
###xml 1355 1359 <span type="species:ncbi:10090">mice</span>
(A) Schematic representation of the wild-type Pfkm locus (top), targeting vector (middle) and targeted allele (bottom). The positions of HindIII (H) and XbaI (X) cleavage sites, the neoR (neo) and herpes simplex virus thymidine kinase (HSV-tk) genes, and the location of PCR primers used to detect wild-type (PFK-Fw and PFK-Rev) and targeted (Neo and PFK-Rev) alleles are shown. (B) PCR analysis of DNA from wild type (+/+), Pfkm+/- (+/-) and Pfkm-/- (-/-) mice using the primers shown in (A). The 0.6 Kb band corresponds to the wild-type allele and the 0.7 Kb band to the mutant allele. (C) Expression of Pfkm in skeletal muscle. Total RNA was obtained from gastrocnemius muscle and analyzed by Northern blot. A representative Northern blot hybridized with a Pfkm probe is shown. (D) PFK activity was determined in skeletal muscle as indicated in Materials and Methods. Basal PFK activity in wild-type mice was 36+/-2.4 U/g tissue. (E-G) Glucose-6-phosphate (E), glucose (F) and glycogen (G) concentrations were determined in perchloric extracts of skeletal muscle from 2-3 month-old wild-type (+/+) and and Pfkm-/- (-/-) mice, in rest and after exercise (5 min), as indicated in Materials and Methods. (H) Serum lactate levels in wild-type (+/+) and Pfkm-/- (-/-) mice, in rest and after exercise (5 min). Results in D-H are mean+/-SEM of five to eight mice per group. *P<0.05, **P<0.01 vs. wild-type.
###end p 12
###begin p 13
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>+/&#8722;</sup></italic>
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 67 83 67 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g001">Figure 1C and 1D</xref>
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 125 132 125 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>+/&#8722;</sup></italic>
###xml 370 374 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Vorgerd1">[12]</xref>
###xml 379 383 379 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 439 442 439 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 435 442 435 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 449 458 449 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g001">Figure 1C</xref>
###xml 508 517 508 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g001">Figure 1D</xref>
###xml 574 583 574 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g001">Figure 1E</xref>
###xml 609 618 609 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g001">Figure 1F</xref>
###xml 634 643 634 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g001">Figure 1G</xref>
###xml 755 758 755 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 751 758 751 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 776 785 776 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g002">Figure 2A</xref>
###xml 935 944 935 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g002">Figure 2B</xref>
###xml 964 967 964 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 960 967 960 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 1008 1017 1008 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g001">Figure 1H</xref>
###xml 1130 1133 1130 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1126 1133 1126 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>+/+</sup></italic>
###xml 1152 1155 1150 1153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1144 1155 1142 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs. Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 363 369 <span type="species:ncbi:9606">humans</span>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
###xml 968 972 <span type="species:ncbi:10090">mice</span>
###xml 1101 1105 <span type="species:ncbi:10090">mice</span>
Pfkm+/- mice showed 50% lower muscle Pfkm expression and activity (Figure 1C and 1D). However, this lower enzyme activity in Pfkm+/- mice did not alter any metabolic parameter, such as glucose-6-phosphate and glycogen levels (data not shown), indicating that half of normal PFK activity is sufficient to prevent metabolic alterations, as observed in heterozygous humans [12]. No Pfkm mRNA transcript was observed in skeletal muscle of Pfkm-/- mice (Figure 1C), in agreement with the lack of enzyme activity (Figure 1D). This deficiency led to increased glucose-6-phosphate (Figure 1E), intracellular glucose (Figure 1F) and glycogen (Figure 1G) content in skeletal muscle. Considerable glycogen storage was also evidenced by histochemical analysis of Pfkm-/- skeletal muscle (Figure 2A). Furthermore, electron microscopy revealed very high subsarcolemmal and intermyofibrillar accumulation of glycogen, which altered fiber morphology (Figure 2B). In addition, Pfkm-/- mice showed lower serum lactate levels (Figure 1H), suggesting lower flux through glycolysis in skeletal muscle. Nevertheless, these mice were normoglycemic (Pfkm+/+, 115+/-12 vs. Pfkm-/-, 113+/-16 mg/dl; (n = 12)). Consistent with this, PFK activity and glucose metabolism were unchanged in the liver (data not shown).
###end p 13
###begin title 14
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
Pfkm-/- mice develop skeletal muscle glycogenosis and exercise intolerance.
###end title 14
###begin p 15
###xml 103 106 103 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 99 106 99 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 295 298 287 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 291 303 283 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup> mice</italic>
###xml 471 474 463 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 467 474 459 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 539 560 531 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 610 611 600 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 617 620 607 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
(A) Glycogen storage evidenced by PAS staining in skeletal muscle sections from wild-type (WT) and Pfkm-/- mice. Scale bar 50 microm. (B) Transmission electron microscopic analysis of skeletal muscle. Arrows show glycogen storage and asterisks point to mitochondria. Scale bar 1 microm. (C) Pfkm-/- mice showing severe muscle cramps after exercise (5 min). (D) ATP and ADP content was determined in perchloric extracts of skeletal muscle from wild-type (+/+) and and Pfkm-/- (-/-) mice, in rest and after exercise (5 min), as described in Materials and Methods. Results are mean+/-SEM of five mice per group. *P<0.05 vs. wild-type.
###end p 15
###begin title 16
###xml 15 19 <span type="species:ncbi:10090">mice</span>
PFKM-deficient mice show exercise intolerance
###end title 16
###begin p 17
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm-</italic>
###xml 247 256 247 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g002">Figure 2C</xref>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 279 282 279 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 338 347 338 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g001">Figure 1E</xref>
###xml 399 408 399 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g001">Figure 1F</xref>
###xml 447 456 447 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g001">Figure 1G</xref>
###xml 11 19 <span type="species:ncbi:9606">patients</span>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
Similar to patients with the classical form of GSDVII, two-month-old Pfkm-null mice were intolerant to exercise. These mice were unable to run for more than 1.5 min. in a treadmill before developing severe muscle cramps, mainly in the rear limbs (Figure 2C). When exercised, Pfkm-/- mice accumulated higher levels of glucose-6-phosphate (Figure 1E), consistent with increased muscle glucose uptake (Figure 1F) and mobilization of muscle glycogen (Figure 1G).
###end p 17
###begin p 18
###xml 97 106 97 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g001">Figure 1H</xref>
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 231 240 231 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g002">Figure 2D</xref>
###xml 381 393 381 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rigor mortis</italic>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 448 451 448 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
Since the muscles of these mice fail to perform glycolysis, lactate did not rise after exercise (Figure 1H). Furthermore, in Pfkm-/- skeletal muscles, ATP and ADP levels were lower even in the resting state and fell with exercise (Figure 2D). These lower levels of ATP agreed with the presence of muscle cramps after exercise, spontaneous cramps during manipulation, and immediate rigor mortis after death (not shown). Thus, skeletal muscle of Pfkm-/- mice was unable to meet the energy demand required to maintain normal contractile activity.
###end p 18
###begin p 19
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 413 422 393 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g003">Figure 3A</xref>
###xml 551 560 531 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g003">Figure 3B</xref>
###xml 743 752 723 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g003">Figure 3C</xref>
###xml 787 791 767 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 791 794 771 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 877 886 857 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g002">Figure 2B</xref>
###xml 1053 1057 1033 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 1057 1060 1037 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1067 1076 1047 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g003">Figure 3D</xref>
###xml 1160 1176 1140 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g001">Figure 1E and 1F</xref>
###xml 1325 1329 1305 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 1329 1332 1309 1312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1357 1366 1337 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g003">Figure 3E</xref>
###xml 1495 1499 1475 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 1499 1502 1479 1482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 795 799 <span type="species:ncbi:10090">mice</span>
###xml 1061 1065 <span type="species:ncbi:10090">mice</span>
###xml 1351 1355 <span type="species:ncbi:10090">mice</span>
###xml 1503 1507 <span type="species:ncbi:10090">mice</span>
Despite low ATP levels in Pfkm-/- mice, the expression of key genes in oxidative metabolism and mitochondrial biogenesis was higher than in wild-type mice, such as peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha), peroxisome proliferator-activated receptor delta (PPARdelta) muscle carnitine palmitoyltransferase 1 (M-CPT-1), citrate synthase (CS) and uncoupling protein 2 (UCP2) (Figure 3A). Moreover, succinate dehydrogenase and NADH-tetrazolium reductase activities, markers of oxidative capacity, were also higher (Figure 3B). Up-regulation of the expression of type I and IIa myosin heavy chain (MyHC-I and IIa) oxidative-type fiber proteins, without changes in the glycolytic MyHC-IIb, was also observed (Figure 3C). Consistent with these findings, Pfkm-/- mice showed proliferation of enlarged mitochondria surrounded by glycogen depots (Figure 2B). Increased expression of genes involved in glucose uptake and phosphorylation, glucose transporter 4 (GLUT4) and hexokinase-II (HK), was found in skeletal muscle of Pfkm-/- mice (Figure 3D), which also agreed with increased muscle glucose and glucose-6-phosphate content (Figure 1E and 1F). In addition, the expression of the pentose phosphate pathway transaldolase (TALDO1) and transketolase (TK) genes was higher in skeletal muscle of Pfkm-/- than in wild-type mice (Figure 3E). Therefore, despite an increased compensatory response, oxidative metabolism was unable to overcome the glycolysis blockade in Pfkm-/- mice.
###end p 19
###begin title 20
Effects of PFKM deficiency in skeletal muscle markers.
###end title 20
###begin p 21
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 499 502 479 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 495 502 475 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 608 611 584 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 604 611 580 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 833 836 809 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 829 836 805 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 981 984 957 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 977 984 953 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 1123 1144 1099 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 1194 1195 1168 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1201 1204 1175 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 837 841 <span type="species:ncbi:10090">mice</span>
###xml 985 989 <span type="species:ncbi:10090">mice</span>
###xml 1177 1181 <span type="species:ncbi:10090">mice</span>
(A) Expression of key genes in oxidative metabolism in skeletal muscle of wild-type and Pfkm-/- mice: Peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha), peroxisome proliferator-activated receptor delta (PPARdelta), carnitine palmytoiltransferase-1 (M-CPT-1), citrate sinthase (CS) and uncoupling protein 2 (UCP-2). (B) Histochemical staining for succinate dehydrogenase (SDH) and NADH-tetrazolium reductase (NADH-TR) activities in skeletal muscle of wild-type and Pfkm-/- mice. Scale bar 25 microm. (C) Expression of myosin heavy chains in skeletal muscle of wild-type and Pfkm-/- mice: Type I, IIa ,and IIb myosin heavy chains (MyHC-I, MyHC-IIa, MyHC-IIb). (D) Expression of the key genes in skeletal muscle glucose uptake, glucose transporter 4 (GLUT4) and hexokinase-II (HKII), in wild-type and Pfkm-/- mice. (E) Expression of pentose phosphate pathway genes, transaldolase (TALDO1) and transketolase (TK), in skeletal muscle of wild-type and Pfkm-/- mice. Relative expression in A, C, D and E was determined by quantitative PCR analysis of total RNA from skeletal muscle, as indicated in Materials and Methods. Results are mean+/-SEM of five mice per group. *P<0.05 vs. wild-type.
###end p 21
###begin title 22
Lack of PFKM alters respiratory muscles and heart
###end title 22
###begin p 23
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 63 66 63 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 171 183 171 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g004">Figure 4A&#8211;4C</xref>
###xml 248 257 248 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g004">Figure 4D</xref>
###xml 283 292 283 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g004">Figure 4E</xref>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 410 413 410 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
Respiratory skeletal muscles were also severely altered in Pfkm-/- mice. The lack of PFK activity in diaphragm, led to increased glucose-6-phosphate and glycogen content (Figure 4A-4C). High accumulation of glycogen was also observed in diaphragm (Figure 4D) and intercostal muscle (Figure 4E) sections by PAS staining. These metabolic alterations may have contributed to alter the respiratory capacity of Pfkm-/- mice.
###end p 23
###begin title 24
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
Effect of Pfkm ablation in diaphragm glucose metabolism and in respiratory muscle glycogen storage.
###end title 24
###begin p 25
###xml 70 91 70 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 297 300 295 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 293 300 291 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 329 350 327 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 400 401 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 410 411 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 417 420 413 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 535 538 531 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 531 538 527 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 614 617 606 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 610 617 602 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
(A) PFK activity was determined in diaphragm extracts as indicated in Materials and Methods. Basal PFK activity in wild-type mice was 26.5+/-4.2 U/g tissue. (B,C) Glucose-6-phosphate (B) and glycogen concentrations (C) were determined in diaphragm perchloric extracts from wild-type (+/+) and Pfkm-/- (-/-) mice, as indicated in Materials and Methods. Results are mean+/-SEM of five mice per group. *P<0.05, **P<0.01 vs. wild-type. (D,E) Glycogen storage evidenced by PAS staining in diaphragm sections (D) from wild-type (wt) and Pfkm-/- mice (scale bar 50 microm) and in intercostal muscle sections (E) from Pfkm-/- mice (scale bar 300 microm). IC, intercostal muscles; R, rib.
###end p 25
###begin p 26
###xml 56 59 56 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Dunaway1">[3]</xref>
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 180 192 180 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g005">Figure 5A&#8211;5C</xref>
###xml 303 312 303 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g005">Figure 5D</xref>
###xml 329 333 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 333 336 333 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 389 392 389 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 385 392 385 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>+/+</sup></italic>
###xml 422 425 420 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 414 425 412 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs. Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 456 462 452 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p&lt;0.01</italic>
###xml 533 549 529 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g005">Figure 5E and 5F</xref>
###xml 693 697 689 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 697 700 693 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 709 718 705 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g005">Figure 5G</xref>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
Cardiac muscle, which expresses the PFKM, PFKL and PFKP [3], showed lower PFK activity in Pfkm-/- mice (about 20% of wild-type) and higher glucose-6-phosphate and glycogen levels (Figure 5A-5C). In addition, increased glycogen storage was also evident in electron microscopy sections of cardiac muscle (Figure 5D). Two-month-old Pfkm-/- mice showed increased (about 55%) heart weight (Pfkm+/+, 4.4+/-0.1 mg/g b.w. vs. Pfkm-/-, 6.9+/-0.3 mg/g b.w.; (n = 5) p<0.01) and developed cardiac hypertrophy and evident cardiomegaly with age (Figure 5E and 5F). Moreover, left ventricle enlargement without interstitial fibrosis was observed after Masson trichromic staining of longitudinal sections of Pfkm-/- hearts (Figure 5G).
###end p 26
###begin title 27
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
Pfkm-/- mice show altered heart glucose metabolism and develop cardiomegaly with age.
###end title 27
###begin p 28
###xml 263 266 261 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 259 266 257 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 327 328 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 337 338 333 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 344 347 340 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 498 501 490 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 494 501 486 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
###xml 689 693 <span type="species:ncbi:10090">mice</span>
(A) PFK activity was determined in heart extracts. Basal PFK activity in wild-type mice was 27.4+/-5.4 U/g tissue. (B,C) Glucose-6-phosphate (B) and glycogen concentrations (C) were determined in heart perchloric extracts from 2-month-old wild-type (+/+) and Pfkm-/- (-/-) mice. Results are mean+/-SEM of five mice per group. *P<0.05, **P<0.01 vs. wild-type. (D) Transmission electron microscopic analysis of cardiac muscle. Arrows show glycogen storage. Scale bar 2 microm. (E,F) One-year-old Pfkm-/- mice develop cardiac hypertrophy, evidenced by hematoxilin-eosin staining of heart sections (scale bar 1 mm) (E) and cardiomegaly (F). (G) Longitudinal sections of heart from 3-month-old mice stained with Masson trichromic reagent (scale bar 1 mm). Inset shows septum sections (scale bar 50 microm).
###end p 28
###begin title 29
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
Pfkm-/- mice develop hemolysis, reticulocytosis and splenomegaly
###end title 29
###begin p 30
###xml 51 55 51 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Ronquist1">[13]</xref>
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 97 100 97 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 201 217 201 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g006">Figure 6A and 6B</xref>
###xml 289 298 289 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g006">Figure 6C</xref>
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 434 437 434 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 484 493 484 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g006">Figure 6D</xref>
###xml 578 582 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 582 585 582 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 628 644 628 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g006">Figure 6E and 6F</xref>
###xml 664 680 664 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g006">Figure 6G and 6H</xref>
###xml 772 788 772 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g006">Figure 6I and 6J</xref>
###xml 939 943 939 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Nakajima1">[14]</xref>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
###xml 842 850 <span type="species:ncbi:9606">patients</span>
Erythrocytes express both PFKM and PFKL isoenzymes [13]. Consistent with the lack of PFKM in Pfkm-/- mice, erythrocytes showed 50% lower PFK activity and accompanying glucose-6-phosphate accumulation (Figure 6A and 6B). This correlated with lower 2,3-bisphosphoglycerate (2,3-BPG) levels (Figure 6C). These metabolic alterations resulted in increased osmotic fragility of erythrocytes (data not shown) and severe hemolysis. Thus, Pfkm-/- mice had very high levels of serum bilirubin (Figure 6D) and lactate dehydrogenase and lower hematocrit (data not shown). As a consequence, Pfkm-/- mice showed compensatory reticulocytosis (Figure 6E and 6F) and splenomegaly (Figure 6G and 6H), which correlated to increased hematopoietic precursors from spleen, but not bone marrow (Figure 6I and 6J). These alterations are features of GSDVII, in which patients show compensated hemolytic anemia with increased serum bilirubin and reticulocyte count [14].
###end p 30
###begin title 31
Reduction of erythrocyte PFK activity leads to hemolysis, reticulocytosis, and splenomegaly.
###end title 31
###begin p 32
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 79 86 79 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 114 135 114 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 290 311 290 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 323 326 323 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 319 326 319 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 559 562 555 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 555 562 551 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 757 760 753 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 753 760 749 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 831 832 825 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 838 841 832 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 767 771 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
(A) PFK activity was determined in blood cell lysates from wild-type (+/+) and Pfkm-/- (-/-) mice as indicated in Materials and Methods. (B,C) Glucose-6-phosphate (B) and 2,3-bisphosphoglycerate (2,3-BPG) (C) concentrations were determined in blood cell perchloric extracts as indicated in Materials and Methods. (D-F) Pfkm-/- show high serum bilirubin levels (D) and reticulocyte number (E,F). New methylene blue stained blood samples were extended on slices (E) and counted (F). Arrows indicate reticulocytes. Scale bar 15 microm. (G,H) Splenomegaly in Pfkm-/- mice. A high increase in spleen size (G) and weight (H) was observed. Scale bar 5 mm. (I,J) Hematopoietic precursors in cultured cells from spleen (I) and femur (J) from wild-type (+/+) and Pfkm-/- (-/-) mice. Results are mean+/-SEM of five to eight mice per group. **P<0.01 vs. wild-type.
###end p 32
###begin title 33
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 23 26 23 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Skeletal muscle of Pfkm-/- mice presents increased vascularization and fiber necrosis and regeneration
###end title 33
###begin p 34
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-McCully1">[15]</xref>
###xml 230 233 230 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 226 233 226 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 437 440 437 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 433 440 433 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 554 563 546 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g007">Figure 7A</xref>
###xml 753 762 741 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g007">Figure 7A</xref>
###xml 856 865 844 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g001">Figure 1F</xref>
###xml 980 989 964 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g007">Figure 7B</xref>
###xml 1148 1152 1124 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Arany1">[16]</xref>
###xml 1190 1193 1166 1169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1186 1193 1162 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 1424 1433 1400 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g007">Figure 7B</xref>
###xml 1507 1510 1483 1486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1503 1510 1479 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 1692 1701 1668 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g007">Figure 7C</xref>
###xml 1840 1843 1816 1819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1836 1843 1812 1819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 1850 1859 1826 1835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000615-g007">Figure 7D</xref>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 1194 1198 <span type="species:ncbi:10090">mice</span>
###xml 1511 1515 <span type="species:ncbi:10090">mice</span>
###xml 1844 1848 <span type="species:ncbi:10090">mice</span>
The decrease of erythrocyte 2,3-BPG levels increases hemoglobin affinity for oxygen and thus impairs oxygen extraction from hemoglobin [15]. Thus, the inability of oxidative metabolism to compensate for glycolysis blockade in Pfkm-/- skeletal muscle may also be due to decreased availability of oxygen to generate sufficient energy. Furthermore, consistent with decreased oxygen availability and marked hemolysis, skeletal muscle of Pfkm-/- mice showed hypoxia, evidenced by higher expression (6-fold) of the hypoxia induced factor 1alpha (HIF-1 alpha) (Figure 7A). Moreover, expression of genes activated by HIF-1alpha, such as pyruvate kinase M (PK-M), lactate dehydrogenase (LDH), and glucose transporter-1 (GLUT1), were up-regulated in this tissue (Figure 7A). This increase in GLUT1 was also consistent with the observed higher intracellular glucose (Figure 1F). The increase in HIF-1alpha was also parallel to increased vascular endothelial growth factor (VEGF) expression (Figure 7B). In addition, it has been described in skeletal muscle that PGC1alpha is induced by a lack of oxygen and that PGC1alpha powerfully regulates VEGF expression [16], which may have also occurred in Pfkm-/- mice. The increase in VEGF led to hypervascularization, as evidenced by greater immunostaining of the platelet endothelial cell adhesion molecule (PECAM-1), an endothelial cell marker, and collagen IV, a basement membrane marker (Figure 7B). Furthermore, the chronic lower levels of ATP in skeletal muscle of Pfkm-/- mice resulted in multiple sites of muscle fiber degeneration and necrosis, characterized by inflammatory infiltration of mononucleated cells and by phagocytosis of necrotic fibers (Figure 7C). In addition, intense skeletal muscle regenerative activity was evidenced by wide distribution of centrally-located nuclei fibers in Pfkm-/- mice (Figure 7D). Thus, severe muscle fiber alterations, in addition to glycogen accumulation, result from PFKM deficiency.
###end p 34
###begin title 35
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
Pfkm-/- mice show increased skeletal muscle hypoxic markers, vascularization, and fiber necrosis.
###end title 35
###begin p 36
###xml 177 180 173 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 173 180 169 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 247 268 243 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 318 319 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 328 329 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 335 338 329 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 691 694 677 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 687 694 673 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
(A) The expression of the hypoxia-induced factor (HIF-1alpha), pyruvate kinase (PK-M), lactate dehydrogenase (LDH), and glucose transporter-1 (GLUT-1) in skeletal muscle of Pfkm-/- mice was determined by quantitative PCR analysis, as indicated in Materials and Methods. Results are mean+/-SEM of four mice per group. *P<0.05, **P<0.01 vs. wild-type. (B) Skeletal muscle sections showed increased immunostaining for VEGF, leading to hypervascularization, as evidenced by greater immunostaining for endothelial cell marker PECAM-1 (scale bar 25 microm) and collagen IV (scale bar 10 microm). Arrows show blood vessels around muscle fiber. (C) Fiber necrosis in skeletal muscle sections of Pfkm-/- mice. Arrows indicate cell infiltration of necrotic fibers (scale bar 25 microm). (D) Muscle fiber regeneration is evidenced by multiple centrally located nuclei (arrows) (scale bar 25 microm).
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 220 223 220 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 216 223 216 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 367 370 367 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Servidei1">[6]</xref>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 176 182 <span type="species:ncbi:9606">humans</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 493 498 <span type="species:ncbi:9606">human</span>
###xml 499 507 <span type="species:ncbi:9606">patients</span>
In this study we show that mice with targeted ablation of the muscle isoform of PFK develop myopathic and hemolytic features similar to those noted in type VII glycogenosis in humans. The early lethality observed in Pfkm-/- mice also resembled the most severe variant of the disease, which presents in infancy and rapidly proceeds to a progressive myopathy and death [6]. Importantly, the full range of phenotypic changes we have observed in our model may impact on diagnosis and detection of human patients since phenotypic heterogeneity is common. In addition, future treatment strategies will need to consider the full extent of pathogenesis to optimize effectivity and safety.
###end p 38
###begin p 39
###xml 82 85 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 78 85 78 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-VillarPalasi1">[17]</xref>
###xml 704 707 704 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 700 707 700 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 925 929 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Bertocci1">[18]</xref>
###xml 930 934 930 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Argov1">[19]</xref>
###xml 1262 1266 1262 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Dimaur1">[20]</xref>
###xml 1426 1430 1426 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Haller1">[21]</xref>
###xml 1610 1614 1610 1614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Haller2">[22]</xref>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 140 145 <span type="species:ncbi:9606">human</span>
###xml 146 154 <span type="species:ncbi:9606">patients</span>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
###xml 816 824 <span type="species:ncbi:9606">patients</span>
###xml 975 983 <span type="species:ncbi:9606">patients</span>
###xml 1282 1290 <span type="species:ncbi:9606">patients</span>
###xml 1455 1463 <span type="species:ncbi:9606">patients</span>
The increased glycogen and glucose-6-phosphate in skeletal muscle observed in Pfkm-/- mice is the classic hallmark described in biopsies of human patients with GSDVII. Suppression of glycolysis impaired the use of glycogen as a fuel leading to increased storage. Moreover, blood glucose cannot be metabolized by the glycolytic pathway causing glucose-6-phosphate accumulation in skeletal muscle. Allosteric activation of glycogen synthase by glucose-6-phosphate may have contributed to increase glycogen storage [17]. Skeletal muscle uses glucose, either blood- or glycogen- derived, as the major fuel during muscular activity. The impairment of the principal catabolic pathway in skeletal muscle of Pfkm-/- mice led to energetic deprivation, which resulted in failure to perform exercise. Similarly, PFKM deficient patients show severe alterations in muscle bioenergetics leading to muscle weakness and exercise intolerance [18],[19]. Ineffective utilization of glycogen in patients with type V glycogen storage (GSDV) or McArdle's disease also leads to impairment of exercise capability. GSDV results from deficiency of the muscle isoform of glycogen phosphorylase, which leads to blockade of glycogen breakdown and to high glycogen storage in skeletal muscle [20]. However, GSDV patients show exercise tolerance after carbohydrate infusion since they can metabolize circulating glucose because glycolytic flux is preserved [21]. In contrast, in GSDVII patients, glucose infusion induces exertional fatigue attributed to an insulin-mediated decreased availability of blood free fatty acids and ketone bodies [22].
###end p 39
###begin p 40
###xml 21 24 21 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 17 24 17 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 216 220 216 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 220 223 220 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 370 374 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Han1">[23]</xref>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Graham1">[24]</xref>
###xml 546 550 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-deLange1">[25]</xref>
###xml 574 578 574 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 578 581 578 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1003 1007 995 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-deLange1">[25]</xref>
###xml 1180 1184 1164 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Wang1">[26]</xref>
###xml 1185 1189 1169 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Liang1">[27]</xref>
###xml 1326 1329 1306 1309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1322 1329 1302 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 1335 1339 1315 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Wende1">[28]</xref>
###xml 1505 1508 1485 1488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1501 1508 1481 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 1697 1700 1677 1680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1693 1700 1673 1680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 1825 1829 1805 1809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 1829 1832 1809 1812 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 582 586 <span type="species:ncbi:10090">mice</span>
###xml 1330 1334 <span type="species:ncbi:10090">mice</span>
###xml 1509 1513 <span type="species:ncbi:10090">mice</span>
###xml 1701 1705 <span type="species:ncbi:10090">mice</span>
###xml 1833 1837 <span type="species:ncbi:10090">mice</span>
Muscle fibers of Pfkm-/- mice failed to generate enough ATP to maintain contractile activity, and mice developed muscle cramps early during the exercise test and with manipulation. In addition, even in rested state, Pfkm-/- mice showed low levels of ATP in the skeletal muscle, which is known to lead to muscle weakness and mitochondrial myopathy in other animal models [23],[24]. Physiological situations involving energy deprivation in skeletal muscle, like exercise and fasting, lead to adaptive changes towards the oxidation of fat as a fuel [25]. In skeletal muscle of Pfkm-/- mice, increased expression of oxidative marker genes and proliferation of enlarged mitochondria revealed an attempt to overcome glycolysis deficiency by shifting substrate metabolism toward a higher reliance on oxidative metabolism. Factors involved in this adaptation included PGC-1alpha, PPARdelta and muscle CPT-1, which are responsible for mitochondrial biogenesis, oxidative phosphorylation and fatty acid oxidation [25]. Furthermore, PGC-1alpha and PPARdelta may have been involved in structural changes towards the formation of oxidative muscle fibers by increasing the expression of MyHC-I [26],[27]. Moreover, PGC-1alpha up-regulation was probably responsible for the increased expression of GLUT-4 and HK-II in skeletal muscle of Pfkm-/- mice [28]. This led to enhanced glucose uptake and phosphorylation, also consistent with the high levels of glucose and glucose-6-phosphate detected in skeletal muscle of Pfkm-/- mice. In addition, the increased expression of transaldolase and transketolase enzymes suggested that glucose could be used through the pentose phosphate pathway in skeletal muscle of Pfkm-/- mice. However, despite these compensatory responses, oxidative metabolism was unable to overcome the glycolysis blockade in Pfkm-/- mice.
###end p 40
###begin p 41
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Gibala1">[29]</xref>
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Owen1">[30]</xref>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 433 436 433 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 681 685 681 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 685 688 685 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1056 1060 1056 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Hakimi1">[31]</xref>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
###xml 689 693 <span type="species:ncbi:10090">mice</span>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
###xml 946 961 <span type="species:ncbi:10090">transgenic mice</span>
Anaplerosis of the tricarboxylic acid (TCA) or Krebs cycle plays a key role in oxidative metabolism in skeletal muscle by providing the TCA cycle with intermediates to permit its continued function. Impaired production of glycolytic substrates could limit oxidative metabolism by reducing concentrations of Krebs cycle intermediates [29],[30]. Blockade of glucose utilization through the glycolysis pathway in skeletal muscle of Pfkm-/- mice may lead to impaired production of the glucose-derived anaplerotic substrates phosphoenolpyruvate and pyruvate. Dysregulation of the TCA cycle intermediates probably impaired oxidative phosphorylation and the ability of skeletal muscle in Pfkm-/- mice to generate an adequate amount of ATP. The significance of the regulation of TCA cycle intermediates in the control of skeletal muscle energy metabolism has clearly been shown in mice overexpressing phosphoenolpyruvate carboxykinase (PEPCK-C). PEPCK-C transgenic mice show increased oxidative capacity in skeletal muscle leading to enhanced exercise performance [31].
###end p 41
###begin p 42
###xml 115 118 115 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 111 118 111 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 355 358 355 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 351 358 351 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 586 589 586 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 582 589 582 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Vora4">[32]</xref>
###xml 705 708 705 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 701 708 701 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 824 828 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Aessopos1">[33]</xref>
###xml 829 833 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Lenox1">[34]</xref>
###xml 922 925 922 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 918 925 918 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 1068 1071 1068 1071 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">slc</sup>
###xml 1064 1071 1064 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pk-1<sup>slc</sup></italic>
###xml 1092 1096 1092 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Morimoto1">[35]</xref>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
###xml 995 999 <span type="species:ncbi:10090">mice</span>
GSDVII is also characterized by compensated hemolytic anemia due to reduction in the erythrocyte PFK activity. Pfkm-/- mice clearly underwent hemolysis and compensatory erythropoiesis evidenced by marked reticulocytosis. Since erythrocytes lack mitochondria, glycolysis is essential for their energy metabolism. Consequently, although erythrocytes of Pfkm-/- mice preserve about half of the PFK activity observed in wild-type mice, it was not enough to maintain erythrocyte integrity. Moreover, the kinetic properties of residual L homotetramer may turn it somehow dysfunctional in Pfkm-/- erythrocytes [32]. Removal of defective erythrocytes was probably responsible for the increased spleen size in Pfkm-/- mice. Splenomegaly has broadly been described as a result of hemolysis or hematopoietic stress in several diseases [33],[34]. Thus, increased hematopoiesis may have also contributed to increase spleen size in Pfkm-/- mice. Similar hematological features are found in spontaneous mutant mice with reduced activity of the glycolytic enzyme pyruvate kinase (Pk-1slc) in red blood cells [35].
###end p 42
###begin p 43
###xml 42 45 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-McCully1">[15]</xref>
###xml 526 529 526 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 522 529 522 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 938 941 938 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 934 941 934 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
Lower PFK activity in erythrocytes of Pfkm-/- mice led to lower concentrations of glycolytic intermediates and 2,3-BPG. In turn, low levels of 2,3-BPG increase the oxygen affinity of hemoglobin, reducing oxygen delivery to the tissues and stimulating erythropoiesis. Skeletal muscle requires large amounts of oxygen during intense exercise and alterations in the affinity of hemoglobin for oxygen could impair muscle performance [15]. Consistent with decreased oxygen availability and marked hemolysis, skeletal muscle of Pfkm-/- mice showed features of hypoxia and angiogenesis together with necrosis and intense regenerative activity. This decreased oxygen availability probably contributed to impair the compensatory oxidative metabolism in the skeletal muscle of PFK deficient mice, exacerbating its loss of functionality. In addition, changes in oxygen delivery to tissues may result in lower respiratory and cardiac function in Pfkm-/- mice.
###end p 43
###begin p 44
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Lynn1">[36]</xref>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Shahrizaila1">[37]</xref>
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Milstein1">[38]</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Pellegrini1">[39]</xref>
###xml 423 426 423 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Servidei1">[6]</xref>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Guibaud1">[40]</xref>
###xml 533 536 533 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 529 536 529 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Finsterer1">[41]</xref>
###xml 1024 1028 1024 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Frey1">[42]</xref>
###xml 1259 1263 1259 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Ashrafian1">[43]</xref>
###xml 1417 1421 1417 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Graham1">[24]</xref>
###xml 1422 1426 1422 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Abel1">[44]</xref>
###xml 1486 1489 1486 1489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1756 1760 1756 1760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Finsterer1">[41]</xref>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
###xml 822 830 <span type="species:ncbi:9606">patients</span>
###xml 1412 1416 <span type="species:ncbi:10090">mice</span>
###xml 1490 1494 <span type="species:ncbi:10090">mice</span>
###xml 1644 1648 <span type="species:ncbi:10090">mice</span>
Involvement of respiratory and cardiac muscles in the pathogenesis of GSDVII is not clearly understood. Myopathic alterations in the respiratory muscles are responsible for loss of respiratory function and even death in a wide spectrum of muscle disorders [36],[37] and other glycogen storage diseases [38],[39]. In addition, premature death due to a respiratory failure is a feature of the severe infantile form of GSDVII [6],[40]. The structural and metabolic abnormalities observed in the diaphragm and respiratory muscles of Pfkm-/- mice suggest impaired respiratory function and may have contributed to the lethality observed in these mice. On the other hand, cardiac abnormalities, such as low voltage electrocardiogram, tachycardia, ventricular hypertrophy and atrium enlargement, have only been described in a few patients [41]. Cardiac hypertrophy may result as an adaptive response to increased workload, and prolonged hypertrophy is associated with increased risk for sudden death or progression to heart failure [42]. Although most frequent causes of heart hypertrophy are chronic hypertension, exercise, myocardial infarction or aortic valve stenosis, several reports point to defects in cardiac energetic metabolism underlying heart enlargement [43]. Thus, heart specific ablation of GLUT-4 glucose transporter or deletion of the adenine nucleotide translocator-1 gene lead to heart hypertrophy in mice [24],[44]. Therefore, altered glucose metabolism in the heart of Pfkm-/- mice may have led to deficient energy production in cardiomyocyte and compensatory chronic heart hypertrophy, which probably increased mortality in these mice. These results suggest that the cardiac pathology in GSDVII may probably be underestimated or misdiagnosed [41]. In addition, this study indicates that symptoms other than classically described may be taken into consideration for the diagnostic of the GSDVII.
###end p 44
###begin p 45
###xml 100 103 100 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 557 560 557 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 553 560 553 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 285 291 <span type="species:ncbi:10090">murine</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
In summary, these results indicate that the skeletal and cardiac muscle impairments observed in Pfkm-/- mice interact with disturbed erythrocyte metabolism to produce the heterogeneous and complex pathology characteristic of type VII glycogen storage disease. The availability of this murine model of GSDVII allows determination of the role of such metabolic alterations in different tissues and organs together with their interactions, and, importantly, allows the study of GSDVII as a systemic disorder, not simply as a muscle glycogenosis. Moreover, Pfkm-/- mice constitute a unique model of GSDVII, which will most likely be very useful for the design and assessment of new therapeutic interventions for this disease.
###end p 45
###begin title 46
Materials and Methods
###end title 46
###begin title 47
###xml 18 21 18 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm<sup>&#8722;/&#8722;</sup></italic>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Generation of Pfkm-/- mice
###end title 47
###begin p 48
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfkm</italic>
###xml 258 262 258 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pfkm</italic>
###xml 771 797 771 797 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AATGCACTCCGATCTGCTCC-3&#8242;</named-content>
###xml 804 841 804 841 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGCCTTCTATCGCCTTCTTG ACGAGTTCTT-3&#8242;</named-content>
###xml 852 878 852 878 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCAAGCAATGCCTAAATCTG-3&#8242;</named-content>
###xml 967 977 967 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
###xml 898 902 <span type="species:ncbi:10090">mice</span>
###xml 953 957 <span type="species:ncbi:10090">Mice</span>
###xml 1206 1210 <span type="species:ncbi:10090">mice</span>
###xml 1306 1310 <span type="species:ncbi:10090">mice</span>
###xml 1363 1368 <span type="species:ncbi:9606">Human</span>
Genomic clones for mouse Pfkm were isolated from a mouse 129/SvJ library (Stratagene). To construct the targeting vector, two fragments of the genomic DNA flanking the exon 3 were subcloned at convenient restriction sites in the pPNT vector. Linearized pPTN/pfkm was transfected into 129/SvJ derived embryonic stem cells (ES) (CMTI-1, Speciality Media). Selection was performed with G418 and gancyclovir, and resistant clones were screened for homologous recombination by Southern blot. Targeted ES cells were injected into blastocysts from C57BL/6J mice and transferred into uteri of pseudopregnant females. Chimeric males were mated to C57BL/6J females and the offspring was screened by PCR analysis using both locus-specific and Neo cassette-specific primers: PFK-Fw: 5'-AATGCACTCCGATCTGCTCC-3'; Neo: 5'-CGCCTTCTATCGCCTTCTTG ACGAGTTCTT-3'; PFK-Rev: 5'-GCAAGCAATGCCTAAATCTG-3'. Homozygous mutant mice were obtained by mating heterozygous littermates. Mice were fed ad libitum with a standard diet (Panlab, Barcelona, Spain) and maintained under a light-dark cycle of 12 h (lights on at 9:00 A.M.). Animals were killed and samples were taken between 9:00 and 10:00 A.M. In the experiments described, male mice, aged 2-3 months were used with littermates as controls. All experimental procedures involving mice were approved by the Ethics Committee in Animal and Human Experimentation of the Universitat Autonoma de Barcelona.
###end p 48
###begin title 49
RNA analysis
###end title 49
###begin p 50
###xml 117 119 117 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pfkm</italic>
###xml 701 723 689 711 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ATACCGCAAAGAGCACGAGAAG</named-content>
###xml 732 757 720 745 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTCAAGAGCAGCGAAAGCGTCACAG</named-content>
###xml 774 795 758 779 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCCATCGTCAACAAAGACGGG</named-content>
###xml 804 825 788 809 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACTTGGGCTCAATGATGTCAC</named-content>
###xml 839 859 823 843 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCACACCAGGCAGTAGCTTT</named-content>
###xml 868 891 852 875 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CAGGAGTTGATTCCAGACAGGTA</named-content>
###xml 901 920 885 904 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TGCCCACACAAGCCATTTG</named-content>
###xml 929 950 913 934 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTGACACGTCTTTGCCAACTT</named-content>
###xml 968 989 948 969 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGCCC TAGATGGCTTTGTGA</named-content>
###xml 998 1018 978 998 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TATCGAGGCTGTGTCGACTG</named-content>
###xml 1030 1050 1010 1030 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CGATCTGTGGAGATGCTGAA</named-content>
###xml 1059 1079 1039 1059 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AATGGGATCAGATGCAAAGC</named-content>
###xml 1090 1112 1070 1092 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TGTCTCCAGCAAAGACTACTGT</named-content>
###xml 1121 1145 1101 1125 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GACTGTACTTGACAAT GTTGGGA</named-content>
###xml 1159 1181 1139 1161 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CAGTTCGGCTATAACACTGGTG</named-content>
###xml 1190 1209 1170 1189 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCCCCCGACAGAGAAGATG</named-content>
###xml 1223 1243 1203 1223 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGAGGGTGGCAAAGTCACTG</named-content>
###xml 1252 1272 1232 1252 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCCATGTCCTCGATCTTGTC</named-content>
###xml 1288 1309 1268 1289 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CGATGA TCTTGCCAGTAATG</named-content>
###xml 1318 1338 1298 1318 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TGATAACTGAGATACCAGCG</named-content>
###xml 1354 1373 1334 1353 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACAGACTAAAGTGAAAGCC</named-content>
###xml 1382 1402 1362 1382 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTCTCAACAGAAAGATGGAT</named-content>
###xml 1415 1435 1395 1415 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GACGGACACTCCATCTGTTG</named-content>
###xml 1444 1465 1424 1445 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CATAGCTCATGGCTGG AACC</named-content>
###xml 1477 1497 1457 1477 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GAAGGGGCTAGGAGCTACCA</named-content>
###xml 1506 1526 1486 1506 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTCGGAG CACACGGAAGTT</named-content>
###xml 1540 1561 1520 1541 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GATTCCAGGCCGTGTATCCAC</named-content>
###xml 1570 1591 1550 1571 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AATCCCCTCCCAGGTTGATGA</named-content>
###xml 1602 1624 1582 1604 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TGGCATACACAGGCAAATACTT</named-content>
###xml 1633 1655 1613 1635 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCCAGCTTGTAAATTCCAGCAA</named-content>
###xml 1670 1689 1650 1669 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGCCCTGCACTCTCGCTTT</named-content>
###xml 1698 1715 1678 1695 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TGCCAGGACGCGCTTGT</named-content>
###xml 1796 1800 1776 1780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Pfaffl1">[45]</xref>
Total RNA was obtained from skeletal muscle samples and analyzed by Northern blot. Northern blots were hybridized to 32P-labeled pfkm cDNA probe labeled following the method of random oligopriming, as described by the manufacturer (Amersham Corp.). For real-time qPCR, 1 microg of RNA samples was used as a template to synthesize cDNA in a volume of 20 microl (Omniscript kit, Qiagen). Oligo-dT was used as a primer for the reaction in the presence of Protector RNase inhibitor (Roche). RT-PCR was performed in a SmartCycler II (Cepheid) using QuantiTect SYBR Green PCR kit (Qiagen). The sequences of the respective sense and antisense oligonucleotide primers were: Primers sequences: PGC-1alpha: (F) ATACCGCAAAGAGCACGAGAAG and (R) CTCAAGAGCAGCGAAAGCGTCACAG; PPARdelta: (F) TCCATCGTCAACAAAGACGGG and (R) ACTTGGGCTCAATGATGTCAC; M-CPT1: (F) GCACACCAGGCAGTAGCTTT and (R) CAGGAGTTGATTCCAGACAGGTA; CS: (F) TGCCCACACAAGCCATTTG and (R) CTGACACGTCTTTGCCAACTT; HIF-1alpha: (F) AGCCC TAGATGGCTTTGTGA and (R) TATCGAGGCTGTGTCGACTG; PK-M: (F) CGATCTGTGGAGATGCTGAA and (R) AATGGGATCAGATGCAAAGC; LDH: (F) TGTCTCCAGCAAAGACTACTGT and (R) GACTGTACTTGACAAT GTTGGGA; GLUT-1: (F) CAGTTCGGCTATAACACTGGTG and (R) GCCCCCGACAGAGAAGATG; MyHC-I: (F) AGAGGGTGGCAAAGTCACTG and (R) GCCATGTCCTCGATCTTGTC; MyHC-IIa: (F) CGATGA TCTTGCCAGTAATG and (R) TGATAACTGAGATACCAGCG; MyHC-IIb: (F) ACAGACTAAAGTGAAAGCC and (R) CTCTCAACAGAAAGATGGAT; GLUT4: (F) GACGGACACTCCATCTGTTG and (R) CATAGCTCATGGCTGG AACC; HKII: (F) GAAGGGGCTAGGAGCTACCA and (R) CTCGGAG CACACGGAAGTT; TALDO1: (F) GATTCCAGGCCGTGTATCCAC and (R) AATCCCCTCCCAGGTTGATGA; TKT: (F) TGGCATACACAGGCAAATACTT and (R) TCCAGCTTGTAAATTCCAGCAA and 36B4: (F) GGCCCTGCACTCTCGCTTT and (R) TGCCAGGACGCGCTTGT. Data was normalized with 36B4 gene values and analyzed as previously described [45].
###end p 50
###begin title 51
Enzyme and metabolite assays
###end title 51
###begin p 52
###xml 197 204 197 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 577 578 565 566 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 808 812 796 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Castano1">[46]</xref>
###xml 963 964 951 952 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 966 967 954 955 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1122 1126 1106 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Keppler1">[47]</xref>
###xml 1205 1209 1189 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Michal1">[48]</xref>
###xml 1353 1357 1337 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Lambrecht1">[49]</xref>
###xml 1358 1362 1342 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Adam1">[50]</xref>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
To determine PFK activity and the concentration of metabolites mice were anesthetized with a mixture of ketamine (100 mg/kg) and xylacine (10 mg/kg). Afterwards, skeletal muscle was freeze clamped in situ, and kept at -80degreesC until analysis. Diaphragm and heart were rapidly excised, weighed, frozen in liquid nitrogen and kept at -80degreesC. Heparinized blood samples were centrifuged, cells collected and frozen. For PFK activity, samples were homogenized in 10 volumes (1 ml/100 mg tissue) of an ice-cold buffer (pH 7.4) containing 20 mM Tris-HCl, 100 mM KCl, 5 mM MgCl2, 5 mM Phosphate Buffer and 30% Glycerol. Samples were centrifugued and PFK activity was determined in the presence of 6 mM fructose 6-phosphate and 18 mM glucose 6-phosphate by spectrophotometric analysis as previously indicated [46]. The concentrations of glycogen, glucose 6-phosphate, glucose and 2,3-BPG were measured in perchloric extracts, which were adjusted to pH 5 with 5 M K2CO3 to determine glycogen and glucose, and to pH 7 for glucose 6-phosphate and 2,3-BPG. Glycogen levels were measured using the alpha-amyloglucosidase method [47]. Glucose and glucose 6-phosphate concentrations were determined enzymatically [48]. 2,3-BPG was determined using a specific kit (Roche Diagnostics GMBH). The concentration of ATP and ADP was determined as described previously [49],[50]. Serum lactate dehydrogenase activity and total bilirubin and lactate levels were measured in the autoanalyzer Pentra400 (ABX Diagnostics) using specific kits (ABX Diagnostics). Glucose concentration in blood was determined by using a Glucometer Elite (Bayer) following the manufacturer's instructions.
###end p 52
###begin title 53
Exercise test
###end title 53
###begin p 54
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were exercised for 5 min on an enclosed treadmill LE-8708 (Panlab) supplied with an electrified grid at the rear of the belt to provide motivation. The speed of the belt was 30 cm/sec.
###end p 54
###begin title 55
Retyculocyte count and hematopoietic cultures
###end title 55
###begin p 56
###xml 319 320 313 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
To determine the number of retyculocytes, blood samples were stained with new methylene blue, extended on slices, and counted under microscope. Hematopoietic cultures were performed in extracts of bone marrow and spleen. Triplicate assays were done in 35 mm plates. Samples were cultured for 7 days at 37degreesC, 5% CO2 and 95% relative humidity in MethoCult GF M3434 medium (StemCell Technologies Inc.). Colonies were counted under inverted microscope including CFU-GM, BFU-E, and CFU-Mix.
###end p 56
###begin title 57
Histochemical analysis
###end title 57
###begin p 58
###xml 570 574 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Nachlas1">[51]</xref>
###xml 575 579 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000615-Dubowitz1">[52]</xref>
Skeletal muscle and heart were fixed for 12 to 24 h in formalin, embedded in paraffin and sectioned. To determine muscle morphology, sections were stained with hematoxylin/eosin. Glycogen content was analyzed by Periodic Acid Schiff (PAS) staining. Heart fibrosis was determined by Masson trichrome staining. For histochemical analysis of succinate dehydrogenase (SDH) and NADH-tetrazolium reductase (NADH-TR) activities, gastrocnemius muscle was dissected and frozen in isopentane supercooled with liquid nitrogen. Frozen sections were analyzed as previously indicated [51],[52].
###end p 58
###begin title 59
Immunohistochemistry
###end title 59
###begin p 60
###xml 129 135 <span type="species:ncbi:9986">rabbit</span>
###xml 141 146 <span type="species:ncbi:10090">mouse</span>
###xml 199 205 <span type="species:ncbi:9986">rabbit</span>
###xml 211 216 <span type="species:ncbi:10090">mouse</span>
###xml 374 377 <span type="species:ncbi:10116">rat</span>
###xml 383 388 <span type="species:ncbi:10090">mouse</span>
###xml 547 553 <span type="species:ncbi:9986">Rabbit</span>
###xml 562 565 <span type="species:ncbi:10116">rat</span>
###xml 595 599 <span type="species:ncbi:9925">goat</span>
###xml 608 614 <span type="species:ncbi:9986">rabbit</span>
###xml 853 858 <span type="species:ncbi:10090">mouse</span>
For immunohistochemical detection of VEGF and collagen IV proteins, paraffin sections were incubated overnight at 4degreesC with rabbit anti-mouse VEGF antibody (Santa Cruz) diluted at 1:50 and with rabbit anti-mouse collagen IV antibody (Chemicon Inc.) diluted at 1:100. For immunohistochemical detection of PECAM-1, cryosections were incubated overnight at 4degreesC with rat anti-mouse PECAM-1 antibody (Pharmingen BDbiosciences) diluted at 1:100. Afterwards, samples were incubated with the biotinylated secondary antibodies (dilution 1:200): Rabbit against rat IgG (Vector laboratories) or goat against rabbit IgG (Vector laboratories). The localization of VEGF was determined using streptavidin conjugate Alexa fluor 488 (Molecular Probes), collagen IV using streptavidin conjugate Alexa fluor 568 (Molecular Probes) and PECAM-1 by ABC peroxidase mouse IgG staining kit (Pierce Biotechnology).
###end p 60
###begin title 61
Transmission electron microscopic analysis
###end title 61
###begin p 62
Skeletal and cardiac muscle samples were obtained and fixed in 2.5% glutaraldehyde and 2% paraformaldehyde for 2 h at 4degreesC. After washing in cold cacodylate buffer, the specimens were postfixed in 1% osmium tetroxide, stained in aqueous uranyl acetate, and then dehydrated through a graded ethanol series and embedded in epoxy resin. Ultrathin sections (600-800 A) from the resin blocks were stained using lead citrate and examined in a transmission electron microscopy (Hitachi H-7000).
###end p 62
###begin title 63
Statistical analysis
###end title 63
###begin p 64
###xml 164 165 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
All values were expressed as mean+/-SEM. Two-tailed P values were calculated by unpaired Student's t test. Differences were considered statistically significant at P values less than 0.05.
###end p 64
###begin p 65
We thank M. Watford, S. Franckhauser, J. Bueren, and C. Mann for helpful discussions.
###end p 65
###begin title 66
References
###end title 66
###begin article-title 67
Isozymes of phosphofructokinase.
###end article-title 67
###begin article-title 68
###xml 12 17 <span type="species:ncbi:9606">human</span>
Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system.
###end article-title 68
###begin article-title 69
###xml 71 74 <span type="species:ncbi:10116">rat</span>
Nature of the subunits of the 6-phosphofructo-1-kinase isoenzymes from rat tissues.
###end article-title 69
###begin article-title 70
Phosphofructokinase deficiency in skeletal muscle. A new type of glycogenosis.
###end article-title 70
###begin article-title 71
Mutations in muscle phosphofructokinase gene.
###end article-title 71
###begin article-title 72
Fatal infantile form of muscle phosphofructokinase deficiency.
###end article-title 72
###begin article-title 73
Fatal Familial Infantile Glycogen-Storage-Disease - Multisystem Phosphofructokinase Deficiency.
###end article-title 73
###begin article-title 74
Angina for 14 years.
###end article-title 74
###begin article-title 75
###xml 44 48 <span type="species:ncbi:9615">dogs</span>
Inherited phosphofructokinase deficiency in dogs with hyperventilation-induced hemolysis: increased in vitro and in vivo alkaline fragility of erythrocytes.
###end article-title 75
###begin article-title 76
Inherited phosphofructokinase deficiency in an American cocker spaniel.
###end article-title 76
###begin article-title 77
###xml 92 95 <span type="species:ncbi:9615">dog</span>
###xml 119 124 <span type="species:ncbi:9606">human</span>
Characterization of the enzymatic lesion in inherited phosphofructokinase deficiency in the dog: an animal analogue of human glycogen storage disease type VII.
###end article-title 77
###begin article-title 78
Muscle phosphofructokinase deficiency in two generations.
###end article-title 78
###begin article-title 79
Familial phosphofructokinase deficiency is associated with a disturbed calcium homeostasis in erythrocytes.
###end article-title 79
###begin article-title 80
Phosphofructokinase deficiency; past, present and future.
###end article-title 80
###begin article-title 81
###xml 58 62 <span type="species:ncbi:9615">dogs</span>
In vivo determination of altered hemoglobin saturation in dogs with M-type phosphofructokinase deficiency.
###end article-title 81
###begin article-title 82
HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha.
###end article-title 82
###begin article-title 83
The role of glucose 6-phosphate in the control of glycogen synthase.
###end article-title 83
###begin article-title 84
###xml 45 50 <span type="species:ncbi:9606">human</span>
Abnormal high-energy phosphate metabolism in human muscle phosphofructokinase deficiency.
###end article-title 84
###begin article-title 85
###xml 28 33 <span type="species:ncbi:9606">human</span>
Muscle energy metabolism in human phosphofructokinase deficiency as recorded by 31P nuclear magnetic resonance spectroscopy.
###end article-title 85
###begin article-title 86
Myophosphorylase deficiency (glycogenosis type V; McArdle disease).
###end article-title 86
###begin article-title 87
Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms.
###end article-title 87
###begin article-title 88
Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency.
###end article-title 88
###begin article-title 89
UCP-mediated energy depletion in skeletal muscle increases glucose transport despite lipid accumulation and mitochondrial dysfunction.
###end article-title 89
###begin article-title 90
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator.
###end article-title 90
###begin article-title 91
Fuel economy in food-deprived skeletal muscle: signaling pathways and regulatory mechanisms.
###end article-title 91
###begin article-title 92
Regulation of muscle fiber type and running endurance by PPARdelta.
###end article-title 92
###begin article-title 93
PGC-1alpha: a key regulator of energy metabolism.
###end article-title 93
###begin article-title 94
A role for the transcriptional coactivator PGC-1alpha in muscle refueling.
###end article-title 94
###begin article-title 95
Anaplerosis of the citric acid cycle: role in energy metabolism of heart and skeletal muscle.
###end article-title 95
###begin article-title 96
The key role of anaplerosis and cataplerosis for citric acid cycle function.
###end article-title 96
###begin article-title 97
###xml 135 140 <span type="species:ncbi:10090">mouse</span>
Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse.
###end article-title 97
###begin article-title 98
Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency.
###end article-title 98
###begin article-title 99
Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia.
###end article-title 99
###begin article-title 100
BMP4 and Madh5 regulate the erythroid response to acute anemia.
###end article-title 100
###begin article-title 101
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Pyruvate kinase deficiency of mice associated with nonspherocytic hemolytic anemia and cure of the anemia by marrow transplantation without host irradiation.
###end article-title 101
###begin article-title 102
Respiratory dysfunction in muscular dystrophy and other myopathies.
###end article-title 102
###begin article-title 103
Respiratory involvement in inherited primary muscle conditions.
###end article-title 103
###begin article-title 104
Fatal infantile muscle phosphorylase deficiency.
###end article-title 104
###begin article-title 105
Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease.
###end article-title 105
###begin article-title 106
[Familial congenital muscular dystrophy caused by phosphofructokinase deficiency].
###end article-title 106
###begin article-title 107
Neurologic and cardiac progression of glycogenosis type VII over an eight-year period.
###end article-title 107
###begin article-title 108
Cardiac hypertrophy: the good, the bad, and the ugly.
###end article-title 108
###begin article-title 109
Hypertrophic cardiomyopathy: a paradigm for myocardial energy depletion.
###end article-title 109
###begin article-title 110
Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart.
###end article-title 110
###begin article-title 111
A new mathematical model for relative quantification in real-time RT-PCR.
###end article-title 111
###begin article-title 112
###xml 51 54 <span type="species:ncbi:10116">rat</span>
Inactivation of phosphofructokinase by glucagon in rat hepatocytes.
###end article-title 112
###begin article-title 113
Glycogen.
###end article-title 113
###begin article-title 114
Glucose 6-Phosphate.
###end article-title 114
###begin article-title 115
ATP determination with hexokinase and glucose-6-phosphate dehidrogenase.
###end article-title 115
###begin article-title 116
Determination of adenosine-5' -diphosphate and adenosine-5' -monophosphate.
###end article-title 116
###begin article-title 117
Cytochemical demonstration of succinic dehydrogenase by the use of a new p-nitrophenyl substituted ditetrazole.
###end article-title 117
###begin p 118
The authors have declared that no competing interests exist.
###end p 118
###begin p 119
AR was the recipient of a predoctoral fellowship from Ministerio de Educacion y Cultura, Spain. This work was supported by grants from Plan Nacional I+D+I (SAF2005-01262), Fundacio La Marato de TV3 (983530), and Instituto Salud Carlos III (CIBER de Diabetes y Enfermedades Metabolicas Asociadas), Spain, and by the European Community (FP6: EUGENE2, LSHM-CT-2004-512013 and EUMODIC, LSHG-CT-2006-037188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 119

